Latest News & Features
Americas
A US House of Representatives committee has accused Teva and Celgene of imposing unjustified price hikes on blockbuster drugs Copaxone and Revlimid. 1 October 2020
Americas
Massachusetts-based Collegium Pharmaceutical has reached a settlement agreement with Teva, resolving its patent litigation over pain medication. 30 September 2020
Americas
Antimicrobial company PureShield has accused its competitor Allied BioScience of infringing ten patents through the sale of a surface disinfectant, which claims protection against COVID-19 for up to seven days. 30 September 2020
Asia
The English High Court has handed down a mixed ruling in a dispute between Edwards Lifesciences and its competitor Meril Life Sciences. 30 September 2020
Americas
A Johnson & Johnson company, Janssen Pharmaceuticals, is seeking a court order blocking Mylan from making copies of its schizophrenia treatment, Invega Trinza, until its patent expires in 2036. 29 September 2020
article
Join us for an interview with Professor Timo Minssen, Director of the Center for Advanced Studies in Biomedical Innovation Law at the University of Copenhagen, as we discuss the current state of IP law in the life sciences; regulating medical AI and big data; and the latest research projects from The University of Copenhagen. 29 September 2020
Americas
The US Court of Appeals for the Federal Circuit has sided with EMD Serono and Pfizer over the invalidation of a multiple sclerosis drug patent, in a defeat for biotech company Biogen. 29 September 2020
Americas
MSD subsidiary Idenix has urged the US Supreme Court to review the overturning of a record $2.5 billion verdict against Gilead Sciences. 28 September 2020
Americas
The US Patent Trial and Appeal Board has invalidated parts of an AbbVie patent covering blood disease drug Imbruvica. 25 September 2020
article
We are delighted to have Justice Birss join our editor-in-chief, Peter Scott, to discuss the UK patent landscape and revisit some of the key judgements of the past few years, and well as to get thoughts on the future of IP in the UK post-Brexit and beyond. 24 September 2020